Testicular signaling is the potential target of perfluorooctanesulfonate-mediated subfertility in male mice

Biology of Reproduction

Volumn 84, Issue 5, 2011, Pages 1016-1023

  Wan, H T ^a   Zhao, Y G ^a   Wong, M H ^a   Lee, K F ^b   Yeung, W S B ^b   Giesy, J P ^c,d   Wong, C K C ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Environment; Gene regulation; Male sexual function; Sperm

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ACTIVIN; ACTIVIN RECEPTOR; CELL RECEPTOR; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CORN OIL; CYTOCHROME P450 17; CYTOCHROME P450 17A1; FOLLISTATIN; GONADOTROPIN; GONADOTROPIN RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INHIBIN; INHIBIN RECEPTOR; MESSENGER RNA; PERFLUOROOCTANESULFONIC ACID; SOMATOMEDIN; SOMATOMEDIN RECEPTOR; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EPIDIDYMIS; GENE; GENE EXPRESSION; GROWTH RATE; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPERMATOZOON COUNT; STAR GENE; SUBFERTILITY; SURVIVAL; TESTOSTERONE BLOOD LEVEL;

MUS; ZEA MAYS;

EID: 79956317679     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.089219     Document Type: Article

References (50)

1. Giesy JP, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 2001; 35:1339-1342.
2. Giesy JP, Kannan K. Perfluorochemical surfactants in the environment. Environ Sci Technol 2002; 36:146A-152A.
3. Dreyer A, Weinberg I, Temme C, Ebinghaus R. Polyfluorinated compounds in the atmosphere of the Atlantic and Southern Oceans: evidence for a global distribution. Environ Sci Technol 2009; 43:6507- 6514.
4. Nakayama SF, Strynar MJ, Reiner JL, Delinsky AD, Lindstrom AB. Determination of perfluorinated compounds in the upper Mississippi river basin. Environ Sci Technol 2010; 44:4103-4109.
5. Jensen AA, Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl 2008; 31:161-169.
6. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 2003; 74:382-392.
7. Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O'Neill EM, Mandel JH, et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 2003; 111:1892-1901.
8. So MK, Yamashita N, Taniyasu S, Jiang Q, Giesy JP, Chen K, Lam PK. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol 2006; 40:2924-2929.
9. Beach SA, Newsted JL, Coady K, Giesy JP. Ecotoxicological evaluation of perfluorooctanesulfonate (PFOS). Rev Environ Contam Toxicol 2006; 186:133-174.
10. Johansson N, Eriksson P, Viberg H. Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci 2009; 108:412-418.
11. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007; 99:366-394.
12. Rosen MB, Schmid JE, Das KP, Wood CR, Zehr RD, Lau C. Gene expression profiling in the liver and lung of perfluorooctane sulfonateexposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid. Reprod Toxicol 2009; 27:278-288.
13. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 2003; 74:369-381.
14. Hasegawa R, Koizumi M, Hirose A. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate. Congenit Anom (Kyoto) 2004; 44: 51-59.
15. Joensen UN, Bossi R, Leffers H, Jensen AA, Skakkebaek NE, Jorgensen N. Do perfluoroalkyl compounds impair human semen quality? Environ Health Perspect 2009; 117:923-927.
16. Martin MT, Brennan RJ, Hu W, Ayanoglu E, Lau C, Ren H, Wood CR, Corton JC, Kavlock RJ, Dix DJ. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol Sci 2007; 97:595-613.
17. Qazi MR, Nelson BD, Depierre JW, Abedi-Valugerdi M. 28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity? Toxicology 2010; 267: 132-139.
18. Bjork JA, Lau C, Chang SC, Butenhoff JL, Wallace KB. Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression. Toxicology 2008; 251:8-20.
19. Wang F, Liu W, Jin Y, Dai J, Yu W, Liu X, Liu L. Transcriptional effects of prenatal and neonatal exposure to PFOS in developing rat brain. Environ Sci Technol 2010; 44:1847-1853.
20. Castellano JM, Roa J, Luque RM, Dieguez C, Aguilar E, Pinilla L, Tena-Sempere M. KiSS-1/kisspeptins and the metabolic control of reproduction: physiologic roles and putative physiopathological implications. Peptides 2009; 30:139-145.
21. Pineda R, Aguilar E, Pinilla L, Tena-Sempere M. Physiological roles of the kisspeptin/GPR54 system in the neuroendocrine control of reproduction. Prog Brain Res 2010; 181:55-77.
22. Roseweir AK, Millar RP. The role of kisspeptin in the control of gonadotrophin secretion. Hum Reprod Update 2009; 15:203-212.
23. Sairam MR, Krishnamurthy H. The role of follicle-stimulating hormone in spermatogenesis: lessons from knockout animal models. Arch Med Res 2001; 32:601-608.
24. O'Shaughnessy PJ, Morris ID, Huhtaniemi I, Baker PJ, Abel MH. Role of androgen and gonadotrophins in the development and function of the Sertoli cells and Leydig cells: data from mutant and genetically modified mice. Mol Cell Endocrinol 2009; 306:2-8.
25. Heckert LL, Griswold MD. The expression of the follicle-stimulating hormone receptor in spermatogenesis. Recent Prog Horm Res 2002; 57: 129-148.
26. Misrahi M, Beau I, Meduri G, Bouvattier C, Atger M, Loosfelt H, Ghinea N, Hai MV, Bougneres PF, Milgrom E. Gonadotropin receptors and the control of gonadal steroidogenesis: physiology and pathology. Baillieres Clin Endocrinol Metab 1998; 12:35-66.
27. Barakat B, O'Connor AE, Gold E, de Kretser DM, Loveland KL. Inhibin, activin, follistatin and FSH serum levels and testicular production are highly modulated during the first spermatogenic wave in mice. Reproduction 2008; 136:345-359.
28. Rocha JS, Bonkowski MS, de Franca LR, Bartke A. Effects of mild calorie restriction on reproduction, plasma parameters and hepatic gene expression in mice with altered GH/IGF-I axis. Mech Ageing Dev 2007; 128:317-331.
29. Rosenfeld RG. Endocrinology of growth. Nestle Nutr Workshop Ser Pediatr Program 2010; 65:225-234.
30. Shi Z, Ding L, Zhang H, Feng Y, Xu M, Dai J. Chronic exposure to perfluorododecanoic acid disrupts testicular steroidogenesis and the expression of related genes in male rats. Toxicol Lett 2009; 188:192-200.
31. Berensztein EB, Baquedano MS, Pepe CM, Costanzo M, Saraco NI, Ponzio R, Rivarola MA, Belgorosky A. Role of IGFs and insulin in the human testis during postnatal activation: differentiation of steroidogenic cells. Pediatr Res 2008; 63:662-666.
32. N'Diaye MR, Sun SS, Fanua SP, Loseth KJ, Shaw Wilgis EF, Crabo BG. Growth hormone receptors in the porcine testis during prepuberty. Reprod Domest Anim 2002; 37:305-309.
33. Chandrashekar V, Bartke A, Coschigano KT, Kopchick JJ. Pituitary and testicular function in growth hormone receptor gene knockout mice. Endocrinology 1999; 140:1082-1088.
34. Keene DE, Suescun MO, Bostwick MG, Chandrashekar V, Bartke A, Kopchick JJ. Puberty is delayed in male growth hormone receptor genedisrupted mice. J Androl 2002; 23:661-668.
35. Fernie KJ, Shutt JL, Letcher RJ, Ritchie IJ, Bird DM. Environmentally relevant concentrations of DE-7and HBCD alter eggshell thickness and reproductive success of American kestrels. Environ Sci Technol 2009; 43: 2124-2130.
36. Huang DS, O'Sullivan AJ. Short-term oral oestrogen therapy dissociates the growth hormone/insulin-like growth factor-I axis without altering energy metabolism in premenopausal women. Growth Horm IGF Res 2009; 19:162-167.
37. Cocchi D, Tulipano G, Colciago A, Sibilia V, Pagani F, Vigano D, Rubino T, Parolaro D, Bonfanti P, Colombo A, Celotti F. Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat: part 1: effects on somatic growth, growth hormone-axis activity and bone mass in the offspring. Toxicol Appl Pharmacol 2009; 237:127-136.
38. Risbridger GP, Cancilla B. Role of activins in the male reproductive tract. Rev Reprod 2000; 5:99-104.
39. de Kretser DM, Buzzard JJ, Okuma Y, O'Connor AE, Hayashi T, Lin SY, Morrison JR, Loveland KL, Hedger MP. The role of activin, follistatin and inhibin in testicular physiology. Mol Cell Endocrinol 2004; 225:57-64.
40. Casagrandi D, Bearfield C, Geary J, Redman CW, Muttukrishna S. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia. Mol Hum Reprod 2003; 9:199-203.
41. Hsueh AJ, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW, Vale W. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci U S A 1987; 84:5082-5086.
42. Mellor SL, Ball EM, O'Connor AE, Ethier JF, Cranfield M, Schmitt JF, Phillips DJ, Groome NP, Risbridger GP. Activin betaC-subunit heterodi-mers provide a new mechanism of regulating activin levels in the prostate. Endocrinology 2003; 144:4410-4419.
43. Butler CM, Gold EJ, Risbridger GP. Should activin betaC be more than a fading snapshot in the activin/TGFbeta family album? Cytokine Growth Factor Rev 2005; 16:377-385.
44. Hu GX, Lin H, Chen GR, Chen BB, Lian QQ, Hardy DO, Zirkin BR, Ge RS. Deletion of the Igfgene: suppressive effects on adult Leydig cell development. J Androl 2010; 31:379-387.
45. Milardi D, Giampietro A, Baldelli R, Pontecorvi A, De ML. Fertility and hypopituitarism. J Endocrinol Invest 2008; 31:71-74.
46. Austin ME, Kasturi BS, Barber M, Kannan K, MohanKumar PS, MohanKumar SM. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Perspect 2003; 111:1485-1489.
47. Sanderson JT. The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol Sci 2006; 94:3-21.
48. Zhao B, Hu GX, Chu Y, Jin X, Gong S, Akingbemi BT, Zhang Z, Zirkin BR, Ge RS. Inhibition of human and rat 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities by perfluoroalkylated substances. Chem Biol Interact 2010; 188:38-43.
49. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22:659-661.
50. Rhind SM. Anthropogenic pollutants: a threat to ecosystem sustainability? Philos Trans R Soc Lond B Biol Sci 2009; 364:3391-3401.